咨询与建议

限定检索结果

文献类型

  • 71 篇 期刊文献
  • 4 篇 会议

馆藏范围

  • 75 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 50 篇 医学
    • 41 篇 临床医学
    • 14 篇 药学(可授医学、理...
    • 10 篇 基础医学(可授医学...
    • 6 篇 公共卫生与预防医...
    • 4 篇 中西医结合
  • 20 篇 理学
    • 12 篇 数学
    • 9 篇 统计学(可授理学、...
    • 4 篇 生物学
    • 3 篇 系统科学
    • 2 篇 化学
    • 1 篇 地理学
    • 1 篇 科学技术史(分学科...
  • 15 篇 工学
    • 7 篇 生物医学工程(可授...
    • 5 篇 计算机科学与技术...
    • 4 篇 软件工程
    • 2 篇 化学工程与技术
    • 2 篇 安全科学与工程
    • 1 篇 电子科学与技术(可...
    • 1 篇 水利工程
    • 1 篇 环境科学与工程(可...
    • 1 篇 食品科学与工程(可...
    • 1 篇 生物工程
  • 6 篇 管理学
    • 3 篇 管理科学与工程(可...
    • 2 篇 工商管理
    • 2 篇 图书情报与档案管...
  • 2 篇 经济学
    • 1 篇 理论经济学
    • 1 篇 应用经济学
  • 2 篇 法学
    • 1 篇 社会学
  • 1 篇 哲学
    • 1 篇 哲学
  • 1 篇 历史学
    • 1 篇 世界史
  • 1 篇 农学

主题

  • 4 篇 schizophrénie
  • 4 篇 palipéridone
  • 4 篇 thérapeutique
  • 4 篇 antipsychotiques
  • 2 篇 biomarkers
  • 2 篇 statistics
  • 2 篇 oncology
  • 1 篇 study duration
  • 1 篇 strong
  • 1 篇 weighted partial...
  • 1 篇 central subspace
  • 1 篇 mavorixafor
  • 1 篇 neutropenia
  • 1 篇 joint asymptotic...
  • 1 篇 spending functio...
  • 1 篇 survival
  • 1 篇 software package...
  • 1 篇 malnutrition -- ...
  • 1 篇 pain
  • 1 篇 linear rank test

机构

  • 7 篇 biostatistics & ...
  • 5 篇 emea maf janssen...
  • 5 篇 psychiatry hospi...
  • 5 篇 emea maf janssen...
  • 4 篇 psychiatry and n...
  • 4 篇 psychiatry dicle...
  • 4 篇 emea medical aff...
  • 4 篇 clinica psichiat...
  • 4 篇 emea medical aff...
  • 4 篇 biostatistics & ...
  • 4 篇 hospital clínic ...
  • 3 篇 chu de strasbour...
  • 3 篇 biostatistics an...
  • 3 篇 emea medical aff...
  • 2 篇 biostatistics an...
  • 2 篇 dicle university...
  • 2 篇 biostatistics an...
  • 2 篇 psychiatry centr...
  • 2 篇 biostatistics an...
  • 2 篇 biostatistics an...

作者

  • 12 篇 schreiner a.
  • 12 篇 cherubin p.
  • 9 篇 bergmans p.
  • 9 篇 parellada e.
  • 9 篇 carpiniello b.
  • 9 篇 vidailhet p.
  • 8 篇 hargarter l.
  • 6 篇 rancans e.
  • 6 篇 bez y.
  • 3 篇 hargater l.
  • 3 篇 mertens c.
  • 3 篇 burmester gerd r
  • 3 篇 lin ji
  • 2 篇 c. roehrborn
  • 2 篇 jayawardena shya...
  • 2 篇 lévy-leduc célin...
  • 2 篇 zhang yiding
  • 2 篇 quan hui
  • 2 篇 ternès nils
  • 2 篇 fan chunpeng

语言

  • 74 篇 英文
  • 1 篇 中文
检索条件"机构=Biostatistics and programming"
75 条 记 录,以下是31-40 订阅
排序:
EFFICACY AND SAFETY OF EXPERIMENTAL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS VERSUS AXICABTAGENE CILOLEUCEL (YESCARTA) FOR THE TREATMENT OF RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA: MATCHING ADJUSTED INDIRECT COMPARISONS AND SYSTEMATIC REVIEW
收藏 引用
Hematology, Transfusion and Cell Therapy 2021年 43卷 S256-S256页
作者: B Weinstein B Muresan S Solano AV Macedo Y Lee Y Su Y Ahn C Camargo G Kim D Carpenter Department of Environmental Health Sciences School of Public Health University at Albany Rensselaer United Kingdom Health Sciences Unit University of Groningen University Medical Center Groningen Groningen The Netherlands Principles and Practice of Clinical Research (PPCR) Program ECPE Harvard T.H. Chan School of Public Health Boston United Kingdom Hematology Clinic Hospital da Polícia Militar Belo Horizonte MG Brazil Department of Pharmaceutical Sciences School of Pharmacy Texas Tech University Health Sciences Center Amarillo United Kingdom Inari Medical Biostatistics and Programming Department Irvine United Kingdom Department of Plastic Surgery Faculdade de Medicina Universidade de São Paulo (FMUSP) São Paulo SP Brazil Institute of Experimental and Clinical Pharmacology and Toxicology Faculty of Medicine University of Freiburg Freiburg Germany Institute for Health and the Environment University at Albany Rensselaer United Kingdom
Introduction Despite the high response rates seen with Chimeric Antigen Receptor (CAR) T-cell therapy for relapsed/refractory Large B-cell lymphoma (R/R LBCL), post-therapy relapse remains a key challenge. To date, no...
来源: 评论
2376. Incidence ofClostridioides difficileInfection Among United States Medicare Advantage Enrollees
收藏 引用
Open Forum Infectious Diseases 2019年 第SUPPLEMENT_2期6卷 S819–S820页
作者: Heinrich, Kirstin Emir, Birol Ivanova, Jasmina Zhou, Jingying Yu, Holly Health Economics and Outcomes Research Pfizer Inc. Collegeville Pennsylvania Biostatistics Pfizer Inc. New York New York Real-World Data and Analytics Pfizer Inc. New York New York Statistical Programming Pfizer Inc. New York New York Outcome Research Heath Economics Pfizer Inc. Collegeville Pennsylvania
BackgroundClostridioides difficileinfection (CDI) may be life-threatening, and individuals aged ≥ 65 years are at increased risk. CDI burden among Medicare fee-for-service enrollees and nursing home residents in the ...
来源: 评论
K-groups: A generalization of k-means clustering
arXiv
收藏 引用
arXiv 2017年
作者: Li, Songzi Rizzo, Maria L. Biostatistics and Programming Department Pharmaceutical Product Deparment LLC WilmingtonNC28401 Dept. of Mathematics & Statistics Bowling Green State University Bowling GreenOH43403 United States
We propose a new class of distribution-based clustering algorithms, called k-groups, based on energy distance between samples. The energy distance clustering criterion assigns observations to clusters according to a m... 详细信息
来源: 评论
277MO SAR439859, an oral selective estrogen receptor (ER) degrader (SERD), in ER+/ HER2- metastatic breast cancer (mBC): Biomarker analyses from a phase I/II study
收藏 引用
Annals of Oncology 2020年 31卷 S351-S351页
作者: S. Chandarlapaty A. Bardia S. Lord H. Linden V. Pelekanou N. Ternes J. Ming V. Boutet E. Boitier A. Gosselin J. Sang Lee W. Dos-Santos Bele A. Protopopov M. Celanovic A-L. Bauchet M. Campone Medicine Memorial Sloan Kettering Cancer Center New York NY USA Medical Oncology Massachusetts General Hospital Harvard Medical School Boston MA USA Department of Oncology University of Oxford Churchill Hospital Oxford UK Department of Medicine University of Washington Medical Center Seattle WA USA Clinical Precision Oncology-Tranlsational Medicine Early Development Sanofi Cambridge MA USA Biostatistics and Programming Sanofi Paris France Oncology Sanofi Bridgewater NJ USA TMED & Biomarkers & Clinical Bioanalyses Sanofi Paris France Precision Oncology Sanofi Cambridge MA USA Molecular Profiling Precision Oncology Sanofi Paris France Oncology-OMD Sanofi Cambridge MA USA Medical Oncology Institut de Cancérologie de l'Ouest Saint-Herblain France
来源: 评论
069 High baseline serum IL-6 identifies a subgroup of rheumatoid arthritis patients with rapid joint damage and clinical progression and predicts increased sarilumab treatment response
收藏 引用
Rheumatology 2019年 第SUPPLEMENT_3期58卷
作者: Boyapati, Anita Msihid, Jérôme Schwartzman, Sergio Choy, Ernest Burmester, Gerd R Lam, Gordon Kimura, Toshio Sadeh, Jonathan Graham, Neil M H Precision Medicine Regeneron Pharmaceuticals Inc. Tarrytown NY Biostatistics and Programming Sanofi Chilly-Mazarin FRANCE Rheumatology Hospital for Special Surgery New York NY CREATE Center Cardiff University School of Medicine Cardiff UNITED KINGDOM Rheumatology and Clinical Immunology Charité University Medicine Berlin GERMANY Rheumatology Atrium Health Charlotte NC Medical Analytics Regeneron Pharmaceuticals Inc. Tarrytown NY Immunology and Inflammation Franchise Sanofi Genzyme Bridgewater NJ Immunology and Inflammation Regeneron Pharmaceuticals Inc. Tarrytown NY
来源: 评论
Performance evaluation of practice courses using fuzzy cognitive maps
Performance evaluation of practice courses using fuzzy cogni...
收藏 引用
International Conference on Information Technology Based Higher Education and Training, ITHET
作者: Ahmet Albayrak Muammer Albayrak Department of Computer Programming Karadeniz Technical University Trabzon Turkey Department of Biostatistics and Medical Informatics Karadeniz Technical University Trabzon Turkey
In this study, the effect of practical courses (especially robotics) on students' success is evaluated using fuzzy cognitive maps. This study particularly focuses on how practical courses increase the learning ach... 详细信息
来源: 评论
222 Efficacy of sarilumab in patients with rheumatoid arthritis who previously received sarilumab or tocilizumab
收藏 引用
Rheumatology 2018年 第SUPPL_3期57卷
作者: Emery, Paul van Hoogstraten, Hubert Jayawardena, Shyamalie Mangan, Erin Cejas, Paula Verschueren, Patrick Leeds Institute of Rheumatic and Musculoskeletal Medicine University of Leeds Leeds UNITED KINGDOM Global Medical Affairs Sanofi Genzyme Bridgewater NJ USA Biostatistics and Programming Sanofi Bridgewater NJ USA Medical Affairs Regeneron Pharmaceuticals Inc. Tarrytown NY USA Reumatología Hospital Quirónsalud Infanta Luisa Sevilla SPAIN Division of Rheumatology University Hospital Leuven Leuven BELGIUM.
来源: 评论
215 Efficacy of sarilumab in combination with csDMARDs in patients with rheumatoid arthritisand inadequate response to TNF inhibitors by baseline levels of diseaseactivity
收藏 引用
Rheumatology 2018年 第SUPPL_3期57卷
作者: Fleischmann, Roy van Hoogstraten, Hubert Jayawardena, Shyamalie Mangan, Erin K Ching, Daniel Burmester, Gerd R Metroplex Clinical Research Center University of Texas Southwestern Medical Center Dallas TX USA Global Medical Affairs Sanofi Genzyme Bridgewater NJ USA Biostatistics and Programming Sanofi Bridgewater NJ USA Medical Affairs Regeneron Pharmaceuticals Inc Tarrytown NY USA Timaru Medical Specialists Ltd Altoona Center for Clinical Research Timaru NEW ZEALAND Department of Rheumatology and Clinical Immunology Charité - University Medicine Berlin Berlin GERMANY
来源: 评论
214 Efficacy and safety of switching from adalimumab to sarilumab in an open-label extensionof a phase III monotherapy trial in patients with active rheumatoid arthritis
收藏 引用
Rheumatology 2018年 第SUPPL_3期57卷
作者: Burmester, Gerd R Fiore, Stefano Hu, Chih-Chi Fay, Jon Lee, Eun Bong Genovese, Mark C Department of Rheumatology and Clinical Immunology Charité—University Medicine Berlin Berlin GERMANY US Global Medical Affairs Sanofi Genzyme Bridgewater NJ USA Biostatistics and Programming Sanofi Bridgewater NJ USA Medical Affairs Regeneron Pharmaceuticals Inc. Tarrytown NY USA Division of Rheumatology Department of Internal Medicine Seoul National University College of Medicine Seoul KOREA REPUBLIC OF Rheumatology Department Stanford University Medical Center Palo Alto CA USA
来源: 评论
Adaptive design and timeline prediction for cardiovascular event trials for a non-inferiority/superiority claim
收藏 引用
Communications in Statistics Case Studies Data Analysis and Applications 2015年 第2期1卷 71-84页
作者: Quan, Hui Mao, Xuezhou Wu, Yujun Cho, Meehyung Zhao, Peng-Liang Zhang, Ji Bauer, Deborah Biostatistics and Programming Sanofi Bridgewater NJ United States
Cardiovascular event trials can be designed to allow adaptation based on interim results. In this article, we first discuss a strategy either to accept noninferiority at an interim analysis or to continue the study to... 详细信息
来源: 评论